GLSI +4% on Light volume following earlier PR: Greenwich Lifesciences Receives Approval From European Medicines Agency To Combine HLA-A*02,

GLSI +4% on Light volume following earlier PR: Greenwich Lifesciences Receives Approval From European Medicines Agency To Combine HLA-A*02, Non-HLA-A*02 Participants In Europe